Bringing the fundamentals into focus…
Back to Jade Biosciences, Inc.
How Jade Biosciences, Inc. stacks up
JBIO · against 481 other Healthcare companies of similar size
Profitability
18/ 100
Near the bottom of its peers.
Ranked #401 of 482 · scores higher than 15% of peers
Bars: peers in each 10-point band of the profitability score52 peers with a profitability score of 10–19, including JBIO · Click a bar to see the companies
Why profitability scores 18?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 87% of peers. Return on assets: -32.5% vs peer median 1.7%
- a lower return on invested capital: weaker than 85% of peers. Return on invested capital: -39.1% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = JBIO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | JBIO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 456 reported | -39.1% | 3.9% | 14% | 33% | |
| Operating marginHigher is better · 452 reported | Not reported | 5.8% | — | — | 33% |
| Return on assetsHigher is better · 472 reported | -32.5% | 1.4% | 12% | 33% | |
| Return on equityHigher is better · 451 reported | Not reported | 2.5% | — | — | Context only |
| Gross marginHigher is better · 502 reported | 0.0% | 46.5% | 2% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around JBIO| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 2 | 578M USD | 99 | 73 | |
| 395 | 522M USD | 19 | 12 | |
| 401 | 2.21T KRW (≈$1.6B) | 18 | 57 | |
| 401 | 1.0B USD | 18 | 35 | |
| 401 | 555M EUR (≈$611M) | 18 | 25 | |
| 401 | 927M USD | 18 | 41 | |
| 401 | 1.6B USD | 18 | 38 | |
| 401 | 1.6B USD | 18 | 7 | |
| 401 | 749M USD | 18 | 39 | |
| 401 | 994M USD | 18 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score